Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411774 · ClinicalTrials.gov registry record · Phase 3
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
A Phase 3 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 3
- Development phase
- 142
- Enrollment target
NCT01411774 is a Phase 3 study that has completed, run by University of South Florida. The registered enrollment target is 142 participants.
The verdict
NCT01411774, a Phase 3 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 142 participants
- Enrollment target
Study Summary
The investigators are conducting a randomized double-blind placebo-controlled study to assess the efficacy of d-cycloserine augmentation of cognitive-behavioral therapy for the treatment of pediatric obsessive compulsive disorder. This study represents an innovative approach in translating bench research findings into clinical research and testing a new approach for optimizing an effective psychotherapy with a safe non-psychotropic medication.
Interventions
- DRUG d-cycloserine
- BEHAVIORAL Cognitive-behavioral therapy
- DRUG Pill placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2011-06 |
| Est. Completion | 2017-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411774
The ClinicalTrials.gov registry entry for NCT01411774 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which d-cycloserine is the first listed.
NCT01411774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01411774 about?
NCT01411774 is a clinical study titled "D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)". The investigators are conducting a randomized double-blind placebo-controlled study to assess the efficacy of d-cycloserine augmentation of cognitive-behavioral therapy for the treatment of pediatric obsessive compulsive disorder. This study represents an innovative approach in translating bench res...
What is the current status of trial NCT01411774?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 142 participants. The study started on 2011-06. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01411774?
The interventions under investigation include: d-cycloserine (DRUG), Cognitive-behavioral therapy (BEHAVIORAL), Pill placebo (DRUG).
Who is sponsoring clinical trial NCT01411774?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.